Print Page   |   Sign In   |   Join!
News & Press
Filter news by category:

PSHP Newsletters

Displaying page 1 of 2
1  |  2

Student Submissions
Thursday, January 23, 2020
New option for the treatment of Type 2 Diabetes: Rybelsus® (oral semaglutide) »
Alexandra Cerino, PharmD Candidate 2020, University of the Sciences in Philadelphia Diane H. Quinn, PharmD, BC...
Wednesday, December 4, 2019
The Cardiovascular and Renal Benefits of SGLT2 Inhibitors »
Jessica Marie Fraone, Doctor of Pharmacy Candidate 2020 Philadelphia College of Pharmacy Benjamin Pullinger, PharmD...
Tuesday, November 26, 2019
Attending DVSHP Residency Showcase as a Third Year Pharmacy Student »
Written by: Samuel Lin, PharmD Candidate 2021, Philadelphia College of Pharmacy On October 29 th the Delaware Valle...
Tuesday, November 19, 2019
ROSE Trial Review »
Rick Carlson, Doctor of Pharmacy Candidate 2020 Duquesne University School of Pharmacy David E. Zimmerman, Pha...
Thursday, November 14, 2019
Pexidartinib (TURALIO™): A new approval gives hope for a rare form of soft tissue sarcomas »
Erin Alworth, PharmD Candidate 2020, Duquesne University School of Pharmacy  Preceptor: Karen Fancher, Phar...
Tuesday, November 5, 2019
A Trip to the Capitol »
Written by: Jeel Dudhat and Kiley Margolis, PharmD Candidates 2021Temple University School of Pharmacy  ...
Monday, October 28, 2019
Vaping-Associated Pulmonary Disease: What Pharmacists Need to Know »
Alexus Rivas, Pharm.D. Candidate, Class of 2020, Philadelphia College of Pharmacy Precepted by: Karen Tietze, Ph...
Saturday, October 19, 2019
Delirium in the Intensive Care Unit: The Potential Role of Melatonin »
Aoife Iaria, Doctor of Pharmacy Candidate 2020, Duquesne University School of Pharmacy Lauren Finoli, PharmD, BCPS, B...
Monday, September 23, 2019
Recarbrio: Combating Emerging Resistance »
Written by: Jenni Thomas, Doctor of Pharmacy Candidate 2020, Duquesne University School of Pharmacy Precepted by: Lau...
Wednesday, August 21, 2019
Once Daily Dual Antiretroviral Therapy for the Treatment of HIV Infection »
Matty Zimmerman, PharmD Student, Jefferson College of Pharmacy Preceptor: Jason Schafer, PharmD, MPH, BCPS AQ-ID, B...
Friday, June 21, 2019
Doravirine, a Promising New HIV-1 Novel Therapy »
The DRIVE-FORWARD and DRIVE-AHEAD trials indicate doravirine as a new therapy for HIV-1 in treatment naive patients....
Monday, May 13, 2019
Our Experience as Second Year Pharmacy Students at the PSHP Student Jeopardy Competition »
Authors: Emily Farina & Monica Woloshin, Jefferson College of Pharmacy Class of 2021 Faculty Advisor: Bhavik Shah...
Friday, April 19, 2019
A New Breakthrough in Migraine Treatment – Aimovig (erenumab) »
Allison Tempo, Doctor of Pharmacy Candidate Duquesne University School of Pharmacy David E. Zimmerman, PharmD, BCPS,...
Wednesday, March 20, 2019
Ivosidenib (Tibsovo®) for the treatment of relapsed and refractory acute myeloid leukemia »
Ivosidenib (Tibsovo®) for the treatment of relapsed and refractory acute myeloid leukemia in patients with an isocitrat...
Monday, February 11, 2019
Use of Apixaban in Patients with Nonvalvular Atrial Fibrillation and End Stage Renal Disease »
Boluwatife Familusi, PharmD Candidate 2020, Jefferson College of Pharmacy Preceptor: Raymond Lamore, PharmD, BCPS,...
Monday, December 17, 2018
Succinylcholine and Prolonged Muscle Paralysis with Apnea: An Adverse Drug Reaction Case Report »
Adeline Cruz, PharmD Candidate 2019, Temple University School of Pharmacy  Stanislav Gluhov,  Phar...
Monday, November 26, 2018
Angiotensin II (Giapreza®) - Intravenous Therapy for the Treatment of Septic Shock »
Joyce Jung, PharmD Candidate 2019, Philadelphia College of Pharmacy Oludamilola Olugbile, PharmD, Clinical Pharmacis...
Monday, November 26, 2018
What the MERINO Study Results Mean for the Future of Antibiotic Resistance »
Lakyn Husinka, Doctor of Pharmacy Candidate 2019, Duquesne university School of Pharmacy     Backgrou...
Monday, November 26, 2018
Redefining the Standard: A Review of the SMART and SALT-ED Trials »
Eileen Friery, Doctor of Pharmacy Candidate 2019, Wilkes University Nesbitt School of Pharmacy Amanda Holyk, PharmD, BC...
Thursday, October 18, 2018
Andexxa: First Reversal Agent for Anti-Factor Xa Inhibitors »
Xinwei Li, PharmD Candidate 2019 Philadelphia College of Pharmacy, University of the Sciences in Philadelphia...
Tuesday, September 18, 2018
A New ExeCUTIoner: Plazomicin for complicated UTIs »
Nick Hastain, PharmD Candidate 2019, Jefferson College of Pharmacy Preceptor: Oludamilola Olugbile, PharmD, Clinical...
Wednesday, August 8, 2018
Aspirin for the Prevention of Colorectal Cancer »
Rachel Hatch, PharmD Candidate 2019, Philadelphia College of Pharmacy Natalie Greco, PharmD Candidate 2019, Philadelphia...
Sunday, July 15, 2018
Have you “C-een-the-DIFFerence” in the 2018 Clostridioides difficile Guidelines? »
Have you “C-een-the-DIFFerence” in the 2018 Clostridioides difficile Guidelines ? Brooke Barlow & Ash...
Wednesday, June 20, 2018
Phage Therapy: A Potential Solution to Multidrug-Resistant Bacteria »
Joshua Hildebrand, Pharm.D. Candidate 2020, Duquesne University Dr. David E. Zimmerman, Pharm.D., BCPS, BCCCP I...
Wednesday, May 23, 2018
Alirocumab (Praluent®)– New Role in Lipid Lowering Therapy »
Quynh-Nhu Truong, PharmD Candidate 2019, Philadelphia College of Pharmacy Faculty Advisor: Laura Waite, PharmD, BCPS, CL...
Thursday, April 19, 2018
Treatment of Acute Migraine Headache in the Emergency Department »
Madelyn Stabinski, Duquesne University PharmD Candidate of 2020 David E. Zimmerman, PharmD, BCPS, BCCCP, Assistant Prof...
Thursday, December 21, 2017
Carbapenem-Resistant Enterobacteriaceae (CRE): Where Are We Now and Where Are We Going? »
Student Submission By: Brendan Mangan, Pharm.D. Candidate 2018, Stacy Pasciolla, Pharm.D. Candidate 2018, Jason Gallagher,...
Tuesday, November 21, 2017
Parsabiv ® (etelcalcetide) - the first intravenous drug approved for the treatment of secondary hype »
Mandee Noval, PharmD Candidate 2018 Cole Cecchini, PharmD Candidate 2019 Preceptor - Nicole M. Sifontis, PharmD...
Friday, October 20, 2017   (0 Comments - view/add)
A Student’s Perspective on ASHP Policy Week »
A Student’s Perspective on ASHP Policy Week Brittany Tschaen Pharm.D. Candidate 2018 Jefferson College of...
Tuesday, September 19, 2017   (0 Comments - view/add)
Parsabiv ® (etelcalcetide) - the first intravenous drug approved for the treatment of secondary hype »
Parsabiv ® (etelcalcetide) - the first intravenous drug approved for the treatment of secondary hyperthyroidism in chronic...
Tuesday, September 19, 2017
Cinqair (reslizumab): A new add-on maintenance treatment for patients with eosinophilic phenotype wi »
Cinqair (reslizumab): A new add-on maintenance treatment for patients with eosinophilic phenotype with severe asthma...
Tuesday, September 19, 2017
FDA New Drug Approval: VoseviTM for Hepatitis C therapy in treatment-experienced adults »
FDA New Drug Approval: Vosevi TM for Hepatitis C therapy in treatment-experienced adults Christine Starrs, P...
Tuesday, August 22, 2017
Transitions in a Student Run Clinic »
Student Submission -  Transitions in a Student Run Clinic Bailey Colvin, Doctor of Pharmacy Candidate 2018 Nico...
Monday, July 24, 2017
Historical Impacts of Generic Drug Regulation »
Student Submission - Historical Impacts of Generic Drug Regulation By: Stephanie Liu, PharmD Candidate 2017 Precepto...
Friday, June 30, 2017
Class 1 Drugs, Repurposed Rather Than New »
Student Submission: Class 1 Drugs, Repurposed Rather Than New Jose B. Fernandez Jr., PharmD Class of 2019 Roger Ar...

Displaying page 1 of 2
1  |  2

Membership Management Software Powered by YourMembership  ::  Legal